Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$239,608
+$25,376 QoQ
Shares Held
62,236
+14.8% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $215,063,921 across 28 Biotechnology names. MDXG ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,287,558 | $90,965,971 | |
| 2 | CYTK |
Cytokinetics Inc
|
570,664 | $48,614,865 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
487,017 | $28,310,297 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
77,398 | $23,299,119 | |
| 5 | INSM |
INSMED Inc
|
41,694 | $4,445,414 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,562 | $3,756,271 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,274 | $3,288,549 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
35,881 | $2,808,405 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,608 | 62,236 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $214,232 | 54,236 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $367,177 | 54,236 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $378,567 | 54,236 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $331,381 | 54,236 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $412,193 | 54,236 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $519,480 | 54,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $319,140 | 54,000 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $374,220 | 54,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $415,800 | 54,000 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $473,580 | 54,000 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $393,660 | 54,000 | Shares | Defined | 2023-10-25 | |
| 2023-06-30 | $356,940 | 54,000 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $349,937 | 102,621 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $215,786 | 77,621 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $222,772 | 77,621 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $172,184 | 49,621 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $704,714 | 149,621 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $3,922,961 | 649,497 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $3,963,615 | 654,062 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,243,139 | 658,924 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $6,892,306 | 669,156 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $6,357,961 | 700,216 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||